The Leadership Team at Repare Therapeutics is responsible for guiding the strategic direction and overall management of the company. Comprised of executives from various functions—including discovery, clinical operations, commercial development, and finance—they collaborate to drive innovation in oncology drug development, ensure alignment with business objectives, and foster a culture of scientific excellence. Their collective expertise enables them to make critical decisions that advance the company's mission of targeting specific vulnerabilities in tumor cells.
Adrienne Johnson
Principal Scientist, Computati...
Agnel Sfeir
Co-Founder
Angelos Dovletoglou
Senior Vice President Of Techn...
Biljana Bazdar-Vinov...
Head Of Clinical Operations, V...
Cameron Black
EVP, Discovery
Christopher Kendall ...
VP Of Finance And Fp&a
Daniel Bélanger
EVP, HR
Daniel Durocher
Co-Founder
Esha Jain
Principal Scientist
Frank Sicheri
Co-Founder
Isabel Soria Bretone...
Principal Scientist, Translati...
Kim Seth
EVP & Chief Business Officer
Lloyd M. Segal
Director, President & CEO
Maria Koehler
EVP & Chief Medical Officer
Marisa Wainszelbaum
Vice President, Clinical Scien...
Michael Zinda
EVP & Chief Scientific Officer
Paulina Kallas
VP Tax & Treasury
Philip Herman
EVP, Chief Commercial & Portfo...
Sandra Alves Cpa, Ca
VP Finance & Corporate Control...
Stephanie Guerrera
Vice President, Project Leader...
Stephen Morris
Vice President, Cancer Biology
Steve Forte
EVP & CFO
Yi Xu
Vp, Biometrics
Zhizi Zhao
Vp, Information Technology
View all